Dataset Information


Quality control and stability studies with the monoclonal antibody, trastuzumab: application of 1D- vs. 2D-gel electrophoresis.

ABSTRACT: Recombinant monoclonal antibodies (rmAbs) are medicinal products obtained by rDNA technology. Consequently, like other biopharmaceuticals, they require the extensive and rigorous characterization of the quality attributes, such as identity, structural integrity, purity and stability. The aim of this work was to study the suitability of gel electrophoresis for the assessment of charge heterogeneity, post-translational modifications and the stability of the therapeutic, recombinant monoclonal antibody, trastuzumab. One-dimensional, SDS-PAGE, under reducing and non-reducing conditions, and two-dimensional gel electrophoresis were used for the determination of molecular mass (Mr), the isoelectric point (pI), charge-related isoform patterns and the stability of trastuzumab, subjected to stressed degradation and long-term conditions. For the assessment of the influence of glycosylation in the charge heterogeneity pattern of trastuzumab, an enzymatic deglycosylation study has been performed using N-glycosidase F and sialidase, whereas carboxypeptidase B was used for the lysine truncation study. Experimental data documented that 1D and 2D gel electrophoresis represent fast and easy methods to evaluate the quality of biological medicinal products. Important stability parameters, such as the protein aggregation, can be assessed, as well.


PROVIDER: S-EPMC4013636 | BioStudies | 2014-01-01T00:00:00Z


REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC4966340 | BioStudies
2019-01-01 | S-EPMC6900010 | BioStudies
2018-01-01 | S-EPMC6244757 | BioStudies
2015-01-01 | S-EPMC5737639 | BioStudies
1000-01-01 | S-EPMC5830499 | BioStudies
2020-01-01 | S-EPMC7531515 | BioStudies
1000-01-01 | S-EPMC5620166 | BioStudies
2012-01-01 | S-EPMC3338943 | BioStudies
1967-01-01 | S-EPMC1270487 | BioStudies
1988-01-01 | S-EPMC1149324 | BioStudies